ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Ocugen, Inc. Announces Submission of Emergency Use Authorization Request to the US FDA for Investigational COVID-19 Vaccine COVAXIN™ (BBV152) for Children Ages 2-18 Years
November 08, 2021Ocugen, Inc., a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics and vaccines, announced today that it has submitted a request to the U.S. Food... -
Bharat Biotech announces Phase 3 results of COVAXIN®: India's first COVID-19 vaccine demonstrates interim clinical efficacy of 81%
March 22, 2021Bharat Biotech, a global leader in vaccine innovation, developing vaccines for infectious diseases, announced the first interim analysis of its BBV152 (COVAXIN®). -
Bharat Biotech announces Phase III results of COVAXIN
March 04, 2021The trials involved 25,800 subjects, in partnership with the Indian Council of Medical Research.
Pharma Sources Insight January 2025
